(Q34618577)
Statements
1 reference
Current therapy for Lambert-Eaton myasthenic syndrome: development of 3,4-diaminopyridine phosphate salt as first-line symptomatic treatment (English)
1 reference
A Quartel
1 reference
S Turbeville
1 reference
D Lounsbury
1 reference
1 June 2010
1 reference
1 reference
26
1 reference
6
1 reference
1363-1375
1 reference
Identifiers
1 reference
1 reference